MKI67 and neoplasm: Plant-derived myricetin was shown to act as a pan-KDM4 inhibitor, and its lactic-co-glycolic acid formulation used with enzalutamide synergistically reduced tumor volume and percentage of Ki-67 positive cells in C-R PC mice xenograft of C4-2B cells [31].